A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

Universitair Ziekenhuis Leuven, Lueven

Algemeen Ziekenhuis Maria Middelares, Ghent

Aalborg Universite Hospital, Aalborg

Mount Sinai Chelsea, New York

Mount Sinai Medical Center, New York

Columbia University Medical Center, New York

Istituto Europeo di Oncologia, Milan

University of Virginia, Charlottesville

Duke University Medical Center, Durham

Hospital Universitario Ramon y Cajal, Madrid

HM Centro Integral Oncologico Clara Campal, Madrid

Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón

Augusta University, Augusta

Clinica Universidad de Navarra, Pamplona

Miami Cancer Institute at Baptist Health, Inc., Miami

Miami Cancer Institute- Plantation (MCIP), Miami

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Ospedale Ramazzini di Carpi, Carpi

Ohio State University Clinical Trials Management Office, Columbus

Cleveland Clinic Fairview Hospital, Cleveland

Cleveland Clinic Hillcrest Hospital, Mayfield Heights

Cleveland Clinic, The, Cleveland

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori- IRST S.r.l, Meldola

Karmanos Cancer Institute / Wayne State University, Detroit

University of Missouri Healthcare / Ellis Fischel Cancer Center, Columbia

University of Kansas Cancer Center, Westwood

Texas Oncology - Fort Worth, Dallas

Renovatio Clinical, The Woodlands

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli

Poudre Valley Health System (PVHS), Fort Collins

Stanford Cancer Center South Bay, San Jose

Hackensack University Medical Center, Hackensack

Mater Private, Dublin

Cork University Hospital, Wilton

Fondazione Policlinico Universitario Agostino, Rome

Hospital Universitario Vall d'Hebron, Barcelona

L'Institut Catala d'Oncologia, L'Hospitalet de Llobregat